Cushing disease treatment outcomes were improved among patients with normalized late-night salivary and mean urinary free cortisol levels.

SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

Among individuals undergoing low-dose chest computed tomography (CT) for lung cancer, extensive coronary artery calcium is associated with all-cause death and cardiovascular events.

Five-year breast cancer (BC) risk prediction is improved with the addition of previous screening mammogram images beyond static models.

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Menstrual problems were associated with sleep disturbance, short sleep duration, social jetlag, and later wake up time and bedtime.

Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity and prediabetes.

Significant associations were seen for fasting, 30-min, and 120-min plasma insulin and proinsulin with AS. HealthDay News — Biomarkers of insulin resistance are risk factors for aortic stenosis (AS), ...

Geriatric care for LGBTQ+ adults who live in rural communities requires cultural competence training and diverse health care teams.

Treatment with GLP-1RAs was associated with significant improvements in obstructive sleep apnea-related health outcomes.

Cardiorenal syndrome was associated with an increased risk for depressive symptoms, but lipid indices did not mediate this relationship.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce the risk for clinically important kidney and cardiovascular disease outcomes in individuals with type 2 diabetes.